Shares of Hyperfine, Inc. (NASDAQ:HYPR – Get Free Report) have earned a consensus recommendation of “Hold” from the five brokerages that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $2.03.
A number of equities research analysts have recently commented on HYPR shares. BTIG Research reaffirmed a “buy” rating and issued a $2.00 target price on shares of Hyperfine in a report on Tuesday, September 22nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a report on Friday, July 17th. Finally, B. Riley Financial reiterated a “buy” rating and issued a $1.60 price objective (down from $2.00) on shares of Hyperfine in a research report on Monday, August 10th.
Check Out Our Latest Stock Report on Hyperfine
Institutional Inflows and Outflows
Hyperfine Price Performance
Hyperfine stock opened at $0.93 on Wednesday. The company has a current ratio of 6.15, a quick ratio of 5.45 and a debt-to-equity ratio of 0.36. The company has a fifty day simple moving average of $0.86 and a 200-day simple moving average of $1.16. The stock has a market cap of $98.70 million, a P/E ratio of -2.45 and a beta of 1.45. Hyperfine has a 12-month low of $0.75 and a 12-month high of $2.22.
Hyperfine (NASDAQ:HYPR – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.09). Hyperfine had a negative return on equity of 97.88% and a negative net margin of 210.75%. The firm had revenue of $3.90 million during the quarter, compared to the consensus estimate of $4.13 million. Equities analysts expect that Hyperfine will post -0.34 EPS for the current fiscal year.
Hyperfine Company Profile
Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging (MRI) more accessible and convenient. Its flagship product, the Swoop Portable MR Imaging System, is designed to provide brain imaging at or near the patient’s bedside rather than requiring transport to a traditional MRI suite.
The Swoop system uses a low-field magnetic resonance platform, artificial intelligence-enabled image processing and a mobile design to support neuroimaging in settings such as hospitals, intensive care units and other clinical environments.
Featured Stories
- Five stocks we like better than Hyperfine
- 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.
